Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Endocr Relat Cancer. 2017 Oct 10;25(1):11–19. doi: 10.1530/ERC-17-0377

Table 3.

Relationship between change in visceral adipose tissue (per 1 cm2 reduction) and change in metabolic growth factor concentration during six months

Outcome Δ in Metabolic Growth Factor
Concentration (LS Mean ± SE)		 R2 P
Insulin, pmol/L −0.96±0.41 13.5% 0.025
Glucose, mmol/L −0.03±0.01 21.9% 0.004
Insulin Resistance (HOMA) −0.024±0.009 16.5% 0.013
IGF-1, nmol/L −0.22±0.13 7.6% 0.098
IGFBP-3, nmol/L −1.22±3.16 0.4% 0.701
C-Peptide, mmol/L 0.0007±0.001 0.6% 0.650
Fructosamine, mmol/L −0.16±0.47 0.3% 0.736

LS Mean, least squares mean; SE, standard error; R2, proportion of variability of change in metabolic growth factor concentration explained by change in visceral adipose tissue.